EVALUATION OF GLUCOSE HOMEOSTASIS IN TRANSFUSION-DEPENDENT THALASSEMIC PATIENTS

被引:4
|
作者
Siklar, Zeynep [1 ]
Citak, Funda Erkasar [2 ]
Uysal, Zuemruet [2 ]
Ocal, Gonul [1 ]
Ertem, Mehmet [2 ]
Engiz, Oezlem [1 ]
Adiyaman, Pelin [1 ]
ILeri, Talia [2 ]
Gozdasoglu, Sevgi [2 ]
Berberoglu, Merih [1 ]
机构
[1] Ankara Univ, Sch Med, Dept Pediat Endocrinol, TR-06100 Ankara, Turkey
[2] Ankara Univ, Sch Med, Dept Pediat Haematol, TR-06100 Ankara, Turkey
关键词
diabetes; FPIR; glucose metabolism; insulin resistance; thalassemia major;
D O I
10.1080/08880010802313681
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diabetes is an important problem encountered in thalassemic patients. The severity and type of glucose disturbances vary greatly in different studies. Also the pathogenesis seems to be complex; either insulin deficiency or insulin resistance may mediate the glucose disturbances. In a group of thalassemic patients glucose homeostasis was evaluated. Diabetes prevalence was 1.8%. Forty patients were investigated both with an oral glucose tolerance test and first-phase insulin response. Three patients had impaired fasting glucose, 1 patient had impaired glucose tolerance, and 2 patients had hyperinsulinism. Nineteen of 40 patients who were tested had low first-phase insulin response (47.5%) with below 10th centile. Age, BMI, height SDS, age at diagnosis, age at first blood transfusion, number of blood transfusions in a year, percentage of elevated liver enzyme, and hemoglobin and ferritin levels were not different between patients with low first-phase insulin response to patients with normal first-phase insulin response. Four patients are HCV infected, and only 1 of them had low first-phase insulin response. The study group showed a high rate of impairement in insulin secretion by first-phase insulin response to glucose overload, despite the low rate of insulin resistance. Defect of insulin secretion in thalassemic patients may develop earlier than insulin resistance, and then be accompanied by insulin resistance. Increasing insulin resistance with age and the occurrence of additional factors could lead to detoriation of glucose metabolism.
引用
收藏
页码:630 / 637
页数:8
相关论文
共 50 条
  • [11] Quality of Life (QoL) and the Factors Affecting it in Transfusion-dependent Thalassemic Children
    Kapil Chordiya
    Vikash Katewa
    Pramod Sharma
    Bindu Deopa
    Suman Katewa
    The Indian Journal of Pediatrics, 2018, 85 : 978 - 983
  • [12] Safety and Efficacy of Direct-Acting Antivirals in Transfusion-Dependent Thalassemic Patients with Chronic Hepatitis C
    Onali, Simona
    Maida, Ivana
    Balestrieri, Cinzia
    Arcadu, Francesco
    Urru, Enrico
    Porcu, Davide
    Serra, Giancarlo
    Flore, Giacomo
    Dore, Elena
    Satta, Caterina
    Bitti, Pier Paolo
    Sanna, Maria Grazia
    Serusi, Loredana
    Casale, Michele
    Conti, Maria
    Loi, Martina
    Figorilli, Francesco
    Pasetto, Maria Cristina
    Babudieri, Sergio
    Chessa, Luchino
    HEPATITIS MONTHLY, 2018, 18 (01)
  • [13] Survival and morbidity in transfusion-dependent thalassemic patients on subcutaneous desferrioxamine chelation - Nearly two decades of experience
    Calleja, EM
    Shen, JY
    Lesser, M
    Grady, RW
    New, MI
    Giardina, PJ
    COOLEYS ANEMIA: SEVENTH SYMPOSIUM, 1998, 850 : 469 - 470
  • [14] Retrospective Evaluation of Oral Glucose Tolerance Test in Young Patients with Transfusion-Dependent Beta-Thalassemia
    Dritsa, Maria
    Economou, Marina
    Perifanis, Vasilios
    Teli, Aikaterini
    Christoforidis, Athanasios
    ACTA HAEMATOLOGICA, 2022,
  • [15] Hypoparathyroidism in transfusion-dependent patients with β-thalassemia
    Chern, JPS
    Lin, KH
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (04) : 291 - 293
  • [16] Endocrinopathies in patients with transfusion-dependent ß-thalassemia
    Mehrvar, A.
    Azarkeivan, A.
    Faranoush, M.
    Mehrvar, N.
    Saberinedjad, J.
    Ghorbani, R.
    Vossough, P.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2008, 25 (03) : 187 - 194
  • [17] Hypoparathyroidism in transfusion-dependent patients with β-thalassemia
    Angelopoulos, NG
    Goula, A
    Rombopoulos, G
    Kaltzidou, V
    Katounda, E
    Kaltsas, D
    Tolis, G
    JOURNAL OF BONE AND MINERAL METABOLISM, 2006, 24 (02) : 138 - 145
  • [18] Iron overload in transfusion-dependent patients
    Coates, Thomas D.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 337 - 344
  • [19] Effects of Thalidomide on Erythropoiesis and Iron Homeostasis in Transfusion-Dependent β-Thalassemia
    Yang, Kun
    Liu, Xiaodong
    Peng, Wei
    Hua, Fang
    Li, Lan
    Chen, Kun
    Zhang, Jin
    Luo, Shan
    Li, Wanting
    Ding, Yuxi
    Chen, Jie
    Xiao, Jian
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [20] Nephrolithiasis in Transfusion-Dependent Pediatric Patients
    Yacobovich, Joanne
    Krause, Irit
    Semo-Oz, Rotem
    Tamary, Hannah
    BLOOD, 2014, 124 (21)